Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine if CP-945,598 is effective in the prevention of weight regain in obese subjects.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT05545306 · Obesity, Normal Physiology, and more
NCT04453072 · Obesity, Malignant Neoplasm
NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight
NCT07565051 · Morbid Obesity Requiring Bariatric Surgery
NCT04805502 · Pregnancy, Overweight and Obesity
Pfizer Investigational Site
La Jolla, California
Pfizer Investigational Site
Denver, Colorado
Pfizer Investigational Site
Baton Rouge, Louisiana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions